Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2034

Jul 4, 2019

879% Drug Price Hike is One of 3,400 in 2019 so Far; Rate of Hikes Increasing

Posted by in category: biotech/medical

More funding your way would alleviate what he’s calling out.


Despite public and political pressure, pharma keeps on ratcheting up prices.

Jul 3, 2019

Cholesterol that is too low may boost risk for hemorrhagic stroke

Posted by in categories: biotech/medical, neuroscience

Current guidelines recommend lowering cholesterol for heart disease risk reduction. New findings indicate that if cholesterol dips too low, it may boost the risk of hemorrhagic stroke, according to researchers.

Over a period of nine years, a Penn State-led study examined the relationship between —LDL, commonly known as “bad” —and hemorrhagic stroke. This type of stroke occurs when a blood vessel bursts in the brain.

The researchers found that participants with LDL cholesterol levels below 70 mg/dL had a higher risk of hemorrhagic stroke.

Jul 3, 2019

The neuroscience of autism: New clues for how condition begins

Posted by in categories: biotech/medical, neuroscience

UNC School of Medicine scientists unveiled how a particular gene helps organize the scaffolding of brain cells called radial progenitors necessary for the orderly formation of the brain. Previous studies have shown that this gene is mutated in some people with autism.

Jul 3, 2019

Inhibition of HER2 on tumor cells

Posted by in categories: biotech/medical, nanotechnology

A particularly aggressive, metastasizing form of cancer, HER2-positive breast cancer, may be treated with nanoscopic particles “imprinted” with specific binding sites for the receptor molecule HER2. As reported by Chinese researchers in the journal Angewandte Chemie, the selective binding of the nanoparticles to HER2 significantly inhibits multiplication of the tumor cells.

Jul 3, 2019

Scientists Are Giving Dead Brains New Life. What Could Go Wrong?

Posted by in categories: biotech/medical, neuroscience

Feature

In experiments on pig organs, scientists at Yale made a discovery that could someday challenge our understanding of what it means to die.

Credit credit thomas prior for the new york times.

Jul 3, 2019

How sharing your DNA solves horrible crimes… and stirs a privacy debate

Posted by in category: biotech/medical

But that stirs up a privacy debate.

Jul 3, 2019

The Circle of Willes in Cryonics Perfusion

Posted by in categories: biotech/medical, cryonics, life extension, neuroscience

Blood flows into the brain primarily via the carotid arteries and the vertebral arteries. The Circle of Willis is a circular arterial structure in the brain that connects blood flowing in from the carotid arteries with blood flowing in from the basilar artery (which is fed by the vertebral arteries). Blood flows from the Circle of Willis into brain tissue via the anterior, middle, and posterior cerebral arteries. Many studies have shown that the Circle of Willis is incomplete in most people. A 1998 study of 150 healthy adult volunteers showed a complete Circle of Willis in only 42% of cases — more often complete in younger persons and females [RADIOLOGY; Krabbe-Hartkamp, MJ; 207:103–111 (1998)]. A slightly more encouraging 2002 study of 118 healthy volunteers in the 65–68 age group, showed 47% had a complete Circle of Willis [THE JOURNAL OF CARDIOVASCULAR SURGERY; Macchi, C; 43:887–890 (2002)]

For cryonics purposes, it has been believed that perfusion into the carotid arteries, but not into the vertebral arteries will result in incomplete perfusion of the brain if the Circle of Willis is not complete. In particular, if both posterior communicating arteries are missing, then perfusing only through the carotid arteries will result in no blood getting to parts of the brain supplied by the posterior cerebral arteries. Both posterior communicating arteries were missing in 11% of those in the 1998 study and in 14% of those in the 2002 study cited above.

Nonetheless, a 2008 study showing Circle of Willis complete in only 40% of 99 patients found no case of insufficient perfusion in functional tests of patients given unilateral cerebral perfusion. The authors concluded that “extracranial collateral circulation” provides an alternative pathway to the Circle of Willis for cerebral crossperfusion [EUROPEAN JOURNAL OF CARDIOTHORACIC SURGERY; Urbanski, PP; 33:402–408 (2008)]. Although persons with missing posterior communicating arteries could easily have pathways to opposite sides of the brain, other variants of Circle of Willis incompleteness would be expected to prevent perfusion across hemispheres.

Jul 3, 2019

Space Fence: Connecting the Surveillance and Transhumanist Agendas

Posted by in categories: biotech/medical, military, mobile phones, robotics/AI, satellites, surveillance, transhumanism

Betty Lim


Is a massive, planetary-wide, space surveillance system currently being constructed that aims to monitor you all the way down to your DNA. Officially, the Space Fence is, according to Wikipedia, a 2nd generation space surveillance system being built (started in 2014) by the US Air Force and Lockheed Martin to track artificial satellites and space debris. Its budget is US$1.594 billion, it’s expected to be operational in 2019 and the Space Fence facility will be located in the Marshall Islands along with an option for another radar site in Western Australia. The Space Fence is a resurrection of a program started by Reagan in the 1980s called SDI (Strategic Defense Initiative), commonly known by its nickname “Star Wars.” However, like many exotic weapons of the New World Order, it has a cover purpose and a real purpose. This article exposes the grander implications of the Space Fence – and how it connects to other technology that could be used to enslave you.

What is the Space Fence?

Continue reading “Space Fence: Connecting the Surveillance and Transhumanist Agendas” »

Jul 3, 2019

A Step Closer to Regenerating the Aging Thymus

Posted by in categories: biotech/medical, life extension

Researchers from the Monash Biomedicine Discovery Institute have made progress in the quest to rejuvenate the aging immune system by identifying the factors responsible for the age-related decline of the thymus.

The thymus shrinks as we age

The thymus is one of the most important organs in the body, and it is where thymocytes produced in the bone marrow travel to become new T cells before being trained in the lymph nodes to become the defenders of the adaptive immune system. However, as we get older, the thymus increasingly turns to fat and starts to shrink, causing its ability to produce new T cells to fall dramatically. This process is known as thymic involution and actually begins shortly after puberty, so this is one aspect of aging that begins fairly early in life, although it is many decades later before its decline causes serious health issues.

Jul 3, 2019

Bacteria engineered as Trojan horse for cancer immunotherapy

Posted by in categories: bioengineering, biotech/medical, genetics

The emerging field of synthetic biology—designing new biological components and systems—is revolutionizing medicine. Through the genetic programming of living cells, researchers are creating engineered systems that intelligently sense and respond to diverse environments, leading to more specific and effective solutions in comparison to current molecular-based therapeutics.

At the same time, —using the body’s immune defenses to fight cancer—has transformed over the past decade, but only a handful of have responded, and often results in significant side effects. Designing therapies that can induce a potent, anti– immune response within a solid tumor without triggering systemic toxicity has posed a significant challenge.

Researchers at Columbia Engineering and Columbia University Irving Medical Center (CUIMC) announced today that they are addressing this challenge by engineering a strain of non– that can colonize solid tumors in mice and safely deliver potent immunotherapies, acting as a Trojan Horse that treats tumors from within. The therapy led not only to complete tumor regression in a mouse model of lymphoma, but also significant control of distant, uninjected tumor lesions. Their findings are published today in Nature Medicine.